US Stock MarketDetailed Quotes
FRTX Fresh Tracks Therapeutics
- 0.900
- -0.010-1.07%
15min DelayClose Apr 19 14:25 ET
5.38MMarket Cap-849P/E (TTM)
0.910High0.900Low18.72KVolume0.905Open0.910Pre Close16.97KTurnover0.38%Turnover RatioLossP/E (Static)5.97MShares1.10052wk High0.54P/B4.47MFloat Cap0.45052wk Low--Dividend TTM4.96MShs Float23152.500Historical High--Div YieldTTM1.09%Amplitude0.450Historical Low0.906Avg Price1Lot Size
About Fresh Tracks Therapeutics Company
Fresh Tracks Therapeutics, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. Its pipeline consists of new molecular entities targeting the treatment of the following indications: hyperhidrosis, allergic contact dermatitis, androgenic alopecia, cutaneous t-cell lymphoma and psoriasis. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in 2009 and is headquartered in Boulder, CO.
Company Profile
SymbolFRTX
Company NameFresh Tracks Therapeutics
Listing DateMar 9, 1993
Founded2009
CEOMr. Albert N. Marchio
MarketPink Market
Employees4
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address5777 Central Avenue,Suite 102
CityBoulder
ProvinceColorado
CountryUnited States of America
Zip Code80301
Phone1-720-505-4755
Websitehttp://www.frtx.com
Company Executives
- Name
- Position
- Salary
- Albert N. Marchio
- Chairman of the Board, Chief Executive Officer, Chief Financial Officer, and Secretary
- --
- David R. McAvoy
- General Counsel and Chief Compliance Officer
- --
- Deepak Chadha
- Chief Research and Development Officer and Chief Operating Officer
- --
- Aaron Fox-Collis
- Vice President of Finance and Chief Accounting Officer
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg